Your browser doesn't support javascript.
loading
A lung adenocarcinoma patient with ROS1 fusion and NBN germline mutation achieves long progression-free survival from sintilimab combined with niraparib after failure of ROS1 inhibitors: a case report.
Xu, Fangye; Xiao, Chunmei; Sun, Weijie; He, Yuange; Chalela, Roberto; Masuda, Ken; Ulivi, Paola; Shen, Kai; Shao, Qianwen; Xu, Jiali; Liu, Lianke.
Afiliación
  • Xu F; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Xiao C; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Sun W; Department of Medicine, Beijing GenePlus Clinical Laboratory Co., Ltd., Beijing, China.
  • He Y; Department of Medicine, Beijing GenePlus Clinical Laboratory Co., Ltd., Beijing, China.
  • Chalela R; Respiratory Medicine Department, Hospital del Mar, Barcelona, Spain.
  • Masuda K; Pompeu Fabra University (UPF), Barcelona, Spain.
  • Ulivi P; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Shen K; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Shao Q; Biosciences Laboratory, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRST-IRCCS, Meldola, Italy.
  • Xu J; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Liu L; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ann Transl Med ; 10(16): 912, 2022 Aug.
Article en En | MEDLINE | ID: mdl-36111030
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China